Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-1073
Botulinum Toxin Market is poised to value USD 8805 million by 2028 end at a CAGR of 6.9% during the forecast period 2022 to 2028. The botulinum toxin (Botox) produced by Clostridium botulinum is a neurotoxic protein. Botulism, which causes death if you ingest it, is the same toxin that causes wrinkles, but doctors use it in small doses to treat a variety of health problems, including underarm sweating, cervical dystonia (a neurological disorder that causes severe neck and shoulder muscle contractions), blepharospasm, strabismus, chronic migraines, and overactive bladder. The use of botulinum toxin is widespread in the treatment of aging signs such as frown lines, forehead lines, square jawlines, and crow's feet. It is also expected that the number of manufacturers and users will grow in a variety of economies, further enhancing the market's growth. As a result, the increasing influence of aesthetics among consumers coupled with an increase in manufacturers from various developed and developing countries will further propel Botulinum toxin market growth. A major use of botulinum is in the treatment of strabismus, in addition to being used in the cosmetic industry. Botulinum has been used to treat neurological conditions like spasticity, dystonia, tremor, and others. In addition, recent research has concluded that botulinum is useful for treating autonomic disorders, including hypersecretory disorders and detrusor sphincter dysfunctions. It was the growing demand for botulinum to manage diseases that led to the robust growth of the market. Further, botulinum's growing importance in chemo-denervation and dermal filling has created huge demand among the general public. Additionally, the market grew due to the growing importance of aesthetics and personal appearance among the general population. These factors led to the market's burgeoning growth. Clinically botulinum is used for the treatment of strabismus and huge demand in cosmetic applications. Growing research activities expanded the scope of botulinum for the treatment of neurological conditions like spasticity, dystonia, tremor, and others. Along with this, recent research activities have concluded that botulinum is also used for autonomic disorders like hypersecretory disorders, detrusor sphincter, and others. The growing demand of botulinum in disease management led to the robust growth of the market. Further, the increasing importance of botulinum in chemo-denervation and dermal filling created huge demand among the general population. Along with this, the growing importance of aesthetics and personal appearance among the general population led to the robust growth of the market. All these factors led to the burgeoning growth of the market. High spending capacity and huge demand aesthetics among the general population of developed economies fuelled the growth of the global market. Developed economies like North America and Europe account for more 60% of the market share. The US dominated the North America market due to high penetration among the general population and end-user segment. UK, Germany, France, and Italy dominated the European market. The Asia Pacific is the most opportunistic market space for market players due to the limited presence of manufacturers. It represented a fast-growing region during the forecast period. Latin America and Rest of World is a highly untapped market due to the limited presence of manufacturers and less adoption. FutureWise Market Research has instantiated a report that provides an intricate analysis of Botulinum Toxin Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Botulinum Toxin Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Botulinum Toxin Market: • Allergan • Merz Pharma • Medytox • Galderma • Lanzhou Institute of Biological Products Co.,Ltd • Hugel,Inc • Revanance Therapeutics,Inc • US WorldMeds,LLC • Ipsen group • Eisai Co., Ltd • Evolus, Inc • AbbVie • Pfizer Inc (Note: The list of the major players will be updated with the latest market scenario and trends) Botulinum Toxin Market Segmentation: By Type • Botulinum Toxin A • Botulinum Toxin B By Application • Therapeutic o Chronic Migraine o Spasticity o Overactive Bladder o Cervical Dystonia o Blepharospasm o Others • Aesthetic By End-User • Specialty & Dermatology Clinics • Hospitals & Clinics • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Botulinum Toxin Market Video Sample: Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Botulinum Toxin Market By Type, By Application, By End-User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- Application launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The botulinum toxin (Botox) produced by Clostridium botulinum is a neurotoxic protein. Botulism, which causes death if you ingest it, is the same toxin that causes wrinkles, but doctors use it in small doses to treat a variety of health problems, including underarm sweating, cervical dystonia (a neurological disorder that causes severe neck and shoulder muscle contractions), blepharospasm, strabismus, chronic migraines, and overactive bladder. The use of botulinum toxin is widespread in the treatment of aging signs such as frown lines, forehead lines, square jawlines, and crow's feet. It is also expected that the number of manufacturers and users will grow in a variety of economies, further enhancing the market's growth. As a result, the increasing influence of aesthetics among consumers coupled with an increase in manufacturers from various developed and developing countries will further propel Botulinum toxin market growth. A major use of botulinum is in the treatment of strabismus, in addition to being used in the cosmetic industry. Botulinum has been used to treat neurological conditions like spasticity, dystonia, tremor, and others. In addition, recent research has concluded that botulinum is useful for treating autonomic disorders, including hypersecretory disorders and detrusor sphincter dysfunctions. It was the growing demand for botulinum to manage diseases that led to the robust growth of the market. Further, botulinum's growing importance in chemo-denervation and dermal filling has created huge demand among the general public. Additionally, the market grew due to the growing importance of aesthetics and personal appearance among the general population. These factors led to the market's burgeoning growth.
Clinically botulinum is used for the treatment of strabismus and huge demand in cosmetic applications. Growing research activities expanded the scope of botulinum for the treatment of neurological conditions like spasticity, dystonia, tremor, and others. Along with this, recent research activities have concluded that botulinum is also used for autonomic disorders like hypersecretory disorders, detrusor sphincter, and others. The growing demand of botulinum in disease management led to the robust growth of the market. Further, the increasing importance of botulinum in chemo-denervation and dermal filling created huge demand among the general population. Along with this, the growing importance of aesthetics and personal appearance among the general population led to the robust growth of the market. All these factors led to the burgeoning growth of the market.
High spending capacity and huge demand aesthetics among the general population of developed economies fuelled the growth of the global market. Developed economies like North America and Europe account for more 60% of the market share. The US dominated the North America market due to high penetration among the general population and end-user segment. UK, Germany, France, and Italy dominated the European market. The Asia Pacific is the most opportunistic market space for market players due to the limited presence of manufacturers. It represented a fast-growing region during the forecast period. Latin America and Rest of World is a highly untapped market due to the limited presence of manufacturers and less adoption.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Botulinum Toxin Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Botulinum Toxin Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Botulinum Toxin Market: • Allergan • Merz Pharma • Medytox • Galderma • Lanzhou Institute of Biological Products Co.,Ltd • Hugel,Inc • Revanance Therapeutics,Inc • US WorldMeds,LLC • Ipsen group • Eisai Co., Ltd • Evolus, Inc • AbbVie • Pfizer Inc (Note: The list of the major players will be updated with the latest market scenario and trends)
Botulinum Toxin Market Segmentation:
By Type • Botulinum Toxin A • Botulinum Toxin B
By Application • Therapeutic o Chronic Migraine o Spasticity o Overactive Bladder o Cervical Dystonia o Blepharospasm o Others • Aesthetic
By End-User • Specialty & Dermatology Clinics • Hospitals & Clinics • Others
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Botulinum Toxin Market Video Sample:
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Botulinum Toxin Market By Type, By Application, By End-User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- Application launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Botulinum Toxin Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Botulinum Toxin Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Botulinum Toxin Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Botulinum Toxin Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Botulinum Toxin A 7.2. Botulinum Toxin B 8. Botulinum Toxin Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Therapeutic 8.1.1. Chronic Migraine 8.1.2. Spasticity 8.1.3. Overactive Bladder 8.1.4. Cervical Dystonia 8.1.5. Blepharospasm 8.1.6. Others 8.2. Aesthetic 9. Botulinum Toxin Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Specialty & Dermatology Clinics 9.2. Hospitals & Clinics 9.3. Others 10. North America Botulinum Toxin Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Botulinum Toxin Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Botulinum Toxin Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Botulinum Toxin Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Allergan 16.1.1. Company Overview 16.1.2. Application Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Merz Pharma 16.2.1. Company Overview 16.2.2. Application Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Medytox 16.3.1. Company Overview 16.3.2. Application Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Galderma 16.4.1. Company Overview 16.4.2. Application Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Lanzhou Institute of Biological Products Co.,Ltd 16.5.1. Company Overview 16.5.2. Application Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Hugel,Inc 16.6.1. Company Overview 16.6.2. Application Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Revanance Therapeutics,Inc 16.7.1. Company Overview 16.7.2. Application Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. US WorldMeds,LLC 16.8.1. Company Overview 16.8.2. Application Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Ipsen group 16.9.1. Company Overview 16.9.2. Application Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Eisai Co., Ltd, 16.10.1. Company Overview 16.10.2. Application Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Evolus, Inc 16.11.1. Company Overview 16.11.2. Application Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.AbbVie 16.12.1. Company Overview 16.12.2. Application Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Pfizer Inc 16.13.1. Company Overview 16.13.2. Application Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Botulinum Toxin Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Botulinum Toxin Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Botulinum Toxin Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Botulinum Toxin Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Botulinum Toxin A 7.2. Botulinum Toxin B
8. Botulinum Toxin Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Therapeutic 8.1.1. Chronic Migraine 8.1.2. Spasticity 8.1.3. Overactive Bladder 8.1.4. Cervical Dystonia 8.1.5. Blepharospasm 8.1.6. Others 8.2. Aesthetic
9. Botulinum Toxin Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Specialty & Dermatology Clinics 9.2. Hospitals & Clinics 9.3. Others
10. North America Botulinum Toxin Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Botulinum Toxin Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Botulinum Toxin Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Botulinum Toxin Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Allergan 16.1.1. Company Overview 16.1.2. Application Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Merz Pharma 16.2.1. Company Overview 16.2.2. Application Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Medytox 16.3.1. Company Overview 16.3.2. Application Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Galderma 16.4.1. Company Overview 16.4.2. Application Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Lanzhou Institute of Biological Products Co.,Ltd 16.5.1. Company Overview 16.5.2. Application Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Hugel,Inc 16.6.1. Company Overview 16.6.2. Application Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Revanance Therapeutics,Inc 16.7.1. Company Overview 16.7.2. Application Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. US WorldMeds,LLC 16.8.1. Company Overview 16.8.2. Application Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Ipsen group 16.9.1. Company Overview 16.9.2. Application Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Eisai Co., Ltd, 16.10.1. Company Overview 16.10.2. Application Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Evolus, Inc 16.11.1. Company Overview 16.11.2. Application Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.AbbVie 16.12.1. Company Overview 16.12.2. Application Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Pfizer Inc 16.13.1. Company Overview 16.13.2. Application Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics